Evidence map›Paper›PMID 30814504›Full record

ArticleNature communications2019

Man-made microbial resistances in built environments.

Alexander Mahnert, Christine Moissl-Eichinger, Markus Zojer, David Bogumil, Itzhak Mizrahi, Thomas Rattei, José Luis Martinez, Gabriele Berg

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 207 citations in OpenAlex.

  1. [Is Disinfection of Public Surfaces useful for the Prevention of SARS-CoV-2 Infections?]Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2021
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Applied and environmental microbiology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Microbiology spectrum · 2025
    Article
  19. Review
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Alexander MahnertInstitute of Environmental Biotechnology, Graz University of Technology, Petersgasse 12/I, Graz, 8010, Austria. alexander.mahnert@gmail.com.ORCID http://orcid.org/0000-0001-7083-8894
Christine Moissl-EichingerDepartment of Internal Medicine, Medical University Graz, Auenbruggerplatz 2, Graz, 8036, Austria.
Markus ZojerDivision of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, Vienna, 1090, Austria.
David BogumilDepartment of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Box 653, Beer-Sheva, 84105, Israel.
Itzhak MizrahiDepartment of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Box 653, Beer-Sheva, 84105, Israel.
Thomas RatteiDivision of Computational Systems Biology, Department of Microbiology and Ecosystem Science, University of Vienna, Althanstrasse 14, Vienna, 1090, Austria.ORCID http://orcid.org/0000-0002-0592-7791
José Luis MartinezCentro Nacional de Biotecnologia, CSIC, Calle Darwin 3, Madrid, 28049, Spain.
Gabriele BergInstitute of Environmental Biotechnology, Graz University of Technology, Petersgasse 12/I, Graz, 8010, Austria.
Ben-Gurion University of the Negev · ILGraz University of Technology · ATUniversity of Vienna · ATCentro Nacional de Biotecnología · ESMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a serious threat to global public health, but little is known about the effects of microbial control on the microbiota and its associated resistome. Here we compare the microbiota present on surfaces of clinical settings with other built environments. Using state-of-the-art metagenomics approaches and genome and plasmid reconstruction, we show that increased confinement and cleaning is associated with a loss of microbial diversity and a shift from Gram-positive bacteria, such as Actinobacteria and Firmicutes, to Gram-negative such as Proteobacteria. Moreover, the microbiome of highly maintained built environments has a different resistome when compared to other built environments, as well as a higher diversity in resistance genes. Our results highlight that the loss of microbial diversity correlates with an increase in resistance, and the need for implementing strategies to restore bacterial diversity in certain built environments.

Indexed as

Built EnvironmentDrug Resistance, MicrobialEnvironmental MicrobiologyMicrobiotaBiodiversityGram-Negative BacteriaGram-Positive BacteriaHumansMetagenome

Identifiers

PMID30814504
PMCPMC6393488
OpenAlexW2918959815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.